Study of MHB036C in Participants With Advanced or Metastatic Solid Tumors
NCT05642949
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
400
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumor
Interventions
DRUG:
MHB036C
Sponsor
Minghui Pharmaceutical Pty Ltd